Part III: crystalline fluorapatite-coated hydroxyapatite; potential use as a bacteriostatic agent for both pre-implant cases and retreatment of infected implant sites: a report of 4 cases.
Nordquist
William D
WD
Implant Dentistry of San Diego, San Diego, CA, USA. Georgios_Romanos@urmc.rochester.edu
Krutchkoff
David J
DJ
D000368:Aged; D016301:Alveolar Bone Loss / Q000601:surgery*; D000540:Alveolar Ridge Augmentation / Q000379:methods; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001031:Apatites / Q000627:therapeutic use*; D001672:Biocompatible Materials / Q000627:therapeutic use*; D001861:Bone Regeneration / Q000187:drug effects; D018786:Bone Substitutes / Q000627:therapeutic use*; D019343:Citric Acid / Q000627:therapeutic use; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D003751:Dental Fistula / Q000601:surgery; D015921:Dental Implants; D003790:Dental Pulp Necrosis / Q000601:surgery; D017886:Durapatite / Q000633:toxicity*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016348:Osseointegration / Q000502:physiology; D010012:Osteogenesis / Q000187:drug effects; D012969:Sodium Fluoride / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000601:surgery; D020390:Tooth Socket / Q000601:surgery
D000900:Anti-Bacterial Agents; D001031:Apatites; D001672:Biocompatible Materials; D018786:Bone Substitutes; D020099:Coated Materials, Biocompatible; D015921:Dental Implants; D019343:Citric Acid; D012969:Sodium Fluoride; D017886:Durapatite; C025105:fluorapatite